Results 221 to 230 of about 37,143 (281)

Antiphospholipid antibody-related hepatic vasculitis in a juvenile after non-severe COVID-19: a case report and literature review. [PDF]

Front Immunol
Li Q, Li J, Zhou M, Ge Y, Liu Z, Li T, Zhang L.   +6 more
europepmc   +1 more source

Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry. [PDF]

Rheumatology (Oxford)
Balbi GGM, Ahmadzadeh Y, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Lopez-Pedrera C, Fortin PR, Wahl D, Gerosa M, de Jesús GR, Ji L, Atsumi T, Efthymiou M, Branch DW, Nalli C, Rodriguez Almaraz E, Petri M, Cervera R, Knight JS, Artim-Esen B, Willis R, Bertolaccini ML, Cohen H, Roubey R, Erkan D, de Andrade DCO, for AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (APS ACTION).   +28 more
europepmc   +1 more source

Cryo-EM structure and functional basis of prothrombin recognition by a type I antiprothrombin antiphospholipid antibody.

Blood
Kumar S, Summers B, Basore K, Pengo V, Flaumenhaft R, Pozzi N.   +5 more
europepmc   +1 more source

Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development.

Blood
Müller-Calleja N, Grunz K, Nguyen TS, Posma J, Pedrosa D, Meineck M, Hollerbach A, Braun J, Muth S, Schild H, Saar K, Hübner N, Krishnaswamy S, Royce J, Teyton L, Lemmermann N, Weinmann-Menke J, Lackner KJ, Ruf W.   +18 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antiphospholipid antibody syndrome

Current Opinion in Ophthalmology, 2012
Antiphospholipid syndrome is a rare cause of ocular vaso-occlusive disease, but is associated with significant systemic morbidity and mortality. Thus, early diagnosis and treatment is essential.Although the pathophysiology of antiphospholipid syndrome continues to be poorly understood, there has been continued progress with regard to the relationship ...
Paul, Yang, Jonathan N, Kruh, C Stephen, Foster   +2 more
openaire   +4 more sources

Antiphospholipid antibodies

Australian and New Zealand Journal of Medicine, 1991
This review has focused on some recent developments which have begun to define the immunologic specificity of aPL antibodies. These studies have revealed that these immunoglobulins are more complex than has been realised to date and, more importantly, they offer new approaches to investigate how the prothrombotic diathesis associated with aPL ...
H P, McNeil, S A, Krilis
openaire   +2 more sources

Antiphospholipid antibodies

Annals of Neurology, 1989
AbstractLupus anticoagulants and anticardiolipin antibodies, known collectively as antiphospholipid antibodies, are becoming established as markers for increased risk of thrombosis, including ischemic cerebrovascular disease. In this brief review, we highlight evidence for an against a pathogenetic role of these antibodies in ischemic brain disease and
S R, Levine, K M, Welch
openaire   +2 more sources

Antiphospholipid antibodies and the antiphospholipid antibody syndrome

Drugs of Today, 2000
The antiphospholipid antibody syndrome is a multisystem disorder characterized by persistently elevated antiphospholipid antibodies and/or arterial or venous thrombosis, thrombocytopenia and recurrent spontaneous abortion. Anticardiolipin antibodies and the lupus anticoagulant are different classes of antiphospholipid antibodies associated with this ...
G T, Nahass, S L, Jensen
openaire   +2 more sources

Antiphospholipid antibodies and antiphospholipid syndrome

Current Opinion in Rheumatology, 1995
More than a decade has gone by since the detailed clinical description of antiphospholipid syndrome (APS). Thrombosis, the main complication of the syndrome, can affect vessels of all sizes; the consistent histopathologic lesion is a bland thrombus without inflammation.
M A, Khamashta, G R, Hughes
openaire   +2 more sources